Yourgene Health (AIM:YGEN) has teamed up with payments company Caxton and immunity passport app Prova to support efforts to get people back to work by testing employees for COVID-19.
The international molecular diagnostics group said the collaboration will enable Caxton to offer COVID-19 tests to its extensive network of corporate clients and their employees.
Prova, the immunity passport app which was created by London-based Hooha Innovations, will enable employees to download and request a COVID-19 test via mobile phone.
The results will be automatically delivered securely to the Prova app, allowing the user to share and prove their COVID-19 status without revealing any personal information.
Shares in Yourgene Health were trading 2.78% higher at 18.5p on Tuesday afternoon.
Yourgene said it will bring clinical and technical expertise by providing sample collection kits, training a healthcare professional to take the sample safely and effectively then running the COVID-19 test in its Manchester Citylab facility.
The collaboration will use Yourgene's Clarigene SARS CoV-2 CE-IVD assay when launched to confirm the presence of the virus.
The company said it remains on track to release a 'Research Use Only' version of the test by the end of June 2020 and achieve a CE marked in vitro diagnostic kit to follow in July 2020.
"We are proud to support this effort as the COVID-19 lab partner to this collaboration, working with Caxton and Prova, enabling employees to return to work safely,” said Lyn Rees, CEO of Yourgene.
"Getting Britain back to work is vital for the economy and we are pleased to be able to offer this unique service of test and verify to Caxton's business clients,” added Rupert Lee-Browne, CEO of Caxton.
Follow News & Updates from Yourgene Health here: